Λίστα αντικειμένων
We discussed a case of CNS lymphoma and the diffrent HD regimens.
we favour regimens with Rituxmab, Thiotepa and bu or AraC
we favour regimens with Rituxmab, Thiotepa and bu or AraC
R-Busulfan-thiotepa Rituximab -6 Busulfan 2 days -5, -4 Thiotepa 5 mg/kg days -4 and -3
Other regimens
Regimen without Thiotepa
BUCYE Busulfan 3.2 mg/kg days -7 to -5 Cyclophosphamide 50 mg/kg days -3 and -2 Etoposide 200 mg/m2 days -5 and -4
LEED Cyclophosphamide 60 mg/kg days -4 and -3 Etoposide 250 mg/m2 every 12 h days -4 to -2 Melphalan 130 mg/m2 d a y -1 Dexamethasone 48 mg/d days -4 to -1
Regimen with Thiotepa
BCNU-thiotepa BCNU 400 mg/m2 day -6 Thiotepa 5 mg/kg days -5 and -4
BCNU-thiotepa 10 BCNU 400 mg/m2 day -6 Thiotepa 2 x 5 mg/kg days -5 and -4
bu 2 days bu / thiotepa (https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5473-z )
Regimen without Thiotepa
BUCYE Busulfan 3.2 mg/kg days -7 to -5 Cyclophosphamide 50 mg/kg days -3 and -2 Etoposide 200 mg/m2 days -5 and -4
LEED Cyclophosphamide 60 mg/kg days -4 and -3 Etoposide 250 mg/m2 every 12 h days -4 to -2 Melphalan 130 mg/m2 d a y -1 Dexamethasone 48 mg/d days -4 to -1
Regimen with Thiotepa
BCNU-thiotepa BCNU 400 mg/m2 day -6 Thiotepa 5 mg/kg days -5 and -4
BCNU-thiotepa 10 BCNU 400 mg/m2 day -6 Thiotepa 2 x 5 mg/kg days -5 and -4
bu 2 days bu / thiotepa (https://bmccancer.
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Vadratsikas
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Vadratsikas
Σχετικά Αρχεία
Τηλέφωνα Επικοινωνίας:
Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) Fax : 2613 604066,email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gremail (για θέματα κλινικών μελετών) : gcppatras@gmail.comΜονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261Γραφείο Ιατρών: 2613 604064, 2613 604065, Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)